David Frendewey

David Frendewey

Auto-generated profile, based on publicly available information

David Frendewey

Regeneron Pharmaceuticals, Inc

Research Focus & Metrics

Academic Career Length

48Years (1979-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2006 in Cell
Verified
Journal Article
Closed access
RMRaul Mostoslavsky
Raul Mostoslavsky
KCKatrin F. Chua
Katrin F. Chua
DLDavid B. Lombard
David B. Lombard
WPWendy W. Pang
Wendy W. Pang
MFMiriam R. Fischer
Miriam R. Fischer
FAFrederick W. Alt
Frederick W. Alt

27 April 2007 in Science
Verified
Journal Article
Closed access
PDF file
TTTo-Ha Thai
To-Ha Thai
DCDinis Pedro Calado
Dinis Pedro Calado
SCStefano Casola
Stefano Casola
KAK. Mark Ansel
K. Mark Ansel
CXChangchun Xiao
Changchun Xiao
KRKlaus Rajewsky
Klaus Rajewsky
MicroRNAs are small RNA species involved in biological control at multiple levels. Using genetic deletion and transgenic approaches, we show that the evolutionarily conserved microRNA-155 (miR-155) has an important role in the mammalian immune system, specifically in regulating T helper cell differentiation and the germinal center reaction to produce an optimal T cell–dependent antibody response. miR-155 exerts this control, at least in part, by regulating cytokine production. These results also suggest that individual microRNAs can exert critical control over mammalian differentiation processes in vivo.

31 December 2013 in eLife
Verified
Journal Article
Open access
MSMartin Sauvageau
Martin Sauvageau
LGLoyal A Goff
Loyal A Goff
SLSimona Lodato
Simona Lodato
BBBoyan Bonev
Boyan Bonev
AGAbigail F Groff
Abigail F Groff
JRJohn L Rinn
John L Rinn
Many studies are uncovering functional roles for long noncoding RNAs (lncRNAs), yet few have been tested for in vivo relevance through genetic ablation in animal models. To investigate the functional relevance of lncRNAs in various physiological conditions, we have developed a collection of 18 lncRNA knockout strains in which the locus is maintained transcriptionally active. Initial characterization revealed peri- and postnatal lethal phenotypes in three mutant strains (Fendrr, Peril, and Mdgt), the latter two exhibiting incomplete penetrance and growth defects in survivors. We also report growth defects for two additional mutant strains (linc–Brn1b and linc–Pint). Further analysis revealed defects in lung, gastrointestinal tract, and heart in Fendrr−/− neonates, whereas linc–Brn1b−/− mutants displayed distinct abnormalities in the generation of upper layer II–IV neurons in the neocortex. This study demonstrates that lncRNAs play critical roles in vivo and provides a framework and impetus for future larger-scale functional investigation into the roles of lncRNA molecules.

5 May 2003 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
DVDavid M Valenzuela
David M Valenzuela
AMAndrew J Murphy
Andrew J Murphy
DFDavid Frendewey
David Frendewey
NGNicholas W Gale
Nicholas W Gale
AEAris Nikolaos Economides
Aris Nikolaos Economides
GYGeorge D Yancopoulos
George D Yancopoulos

25 March 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
LMLynn E. Macdonald
Lynn E. Macdonald
MKMargaret Karow
Margaret Karow
SSSean Stevens
Sean Stevens
WAWojtek Auerbach
Wojtek Auerbach
WPWilliam T. Poueymirou
William T. Poueymirou
AMAndrew J. Murphy
Andrew J. Murphy
Significance: This paper describes a major advance in genomic engineering, describing by far the largest genetic humanization of the mouse ever attempted. Six megabases of mouse immune genes were replaced in a precise manner and “in situ” (in the orthologous position) with the corresponding human immune genes using largechimeric bacterial artificial chromosome targeting vectors. The accompanying manuscript demonstrates that the engineered mice function with high efficiency and have already generated therapeutic candidates that have progressed into human trials.

1 November 2002 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
Patrick ProvostPatrick Provost
Patrick Provost
DDDavid Dishart
David Dishart
JDJohanne Doucet
Johanne Doucet
DFDavid Frendewey
David Frendewey
BSBengt Samuelsson
Bengt Samuelsson
OROlof Rådmark
Olof Rådmark
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.